Looking ahead, we are focused on building on the encouraging data reported from efti over the last year
with several important milestones anticipated in the remainder of 2020 and through 2021. AIPAC will
report overall survival data by the end of 2020. More mature data will come from both TACTI-002 and
INSIGHT-004 throughout 2020 and into 2021. There will be further developments from our major
pharma partners.
Looking ahead, we are focused on building on the encouraging...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 29.3¢ | $1.323M | 4.421M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 111754 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 61590 | 3 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |